Molecular Characterization of a Novel Big Defensin from Clam Venerupis philippinarum by Zhao, Jianmin et al.
Molecular Characterization of a Novel Big Defensin from
Clam Venerupis philippinarum
Jianmin Zhao
1, Chenghua Li
1,2*, Aiqin Chen
1, Lingyun Li
3, Xiurong Su
2, Taiwu Li
2
1Yantai Institute of Coastal Zone Research, Chinese Academy of Sciences, Yantai, China, 2Faculty of Life Science and Biotechnology, Ningbo University, Ningbo, China,
3College of Animal Science and Technology, Northeast Agriculture University, Harbin, China
Abstract
Antimicrobial peptides (AMPs) are important mediators of the primary defense mechanism against microbial invasion. In the
present study, a big defensin was identified from Venerupis philippinarum haemocytes (denoted as VpBD) by RACE and EST
approaches. The VpBD cDNA contained an open reading frame (ORF) of 285 bp encoding a polypeptide of 94 amino acids.
The deduce amino acid sequence of VpBD shared the common features of big defensin including disulfide array
organization and helix structure, indicating that VpBD should be a new member of the big defensin family. The mRNA
transcript of VpBD was up-regulated significantly during the first 24 hr after Vibrio anguillarum challenge, which was 7.4-fold
increase compared to that of the control group. Then the expression decreased gradually from 24 hr to 96 hr, and the
lowest expression level was detected at 96 hr post-infection, which was still 3.9-fold higher than that of control. The mature
peptide of VpBD was recombined in Escherichia coli and purified for minimum inhibitory concentration (MIC) determination.
The rVpBD displayed broad-spectrum inhibitory activity towards all tested bacteria with the highest activity against
Staphyloccocus aureus and Pseudomonas putida. These results indicated that VpBD was involved in the host immune
response against bacterial infection and might contribute to the clearance of invading bacteria.
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Introduction
The Manila clam, Venerupis philippinarum, is an important marine
bivalve for commercial fisheries, accounting for about 80% of
mudflat fishery production in China (China Bureau of Fisheries,
2004). In the last decades, clam culture in China is sustaining a
severe mortality problem, and suffering great economic losses [1].
Although positive results have come from treatment of antibiotics,
increasing concerns of antibiotics use have prompted interests in
developing alternative strategies forgrowthandhealth management
[2,3,4]. The gene-encoded cationic antimicrobial peptides (AMPs)
are major humoral components of the innate defense systems [5,6],
which were considered aspromisingtherapeutic candidates for their
innate advantages of less bacterial resistance and very specific
targets [3]. Moreover, the discovery of antimicrobial peptides
provides new clues for a fundamental understanding of the species
immunity response and for further establishment of disease control
in the practice of aquaculture industry.
As cationic and amphiphilic molecules, AMPs showed attractive
perspective as substitutes for antibiotics in aquaculture for their
biochemical diversity, broad specificity against bacteria, fungi or
even virus [6,7,8,9,10,11,12]. In mollusk, the presence of lower
molecular mass AMPs started to be investigated from last decade
[13]. To date, approximately 20 AMPs have been isolated or
cloned from mollusks, mainly from mussels (for review see [14]).
Big defensin is one of the AMPs which possess remarkable
microbicidal activity against Gram-positive, Gram-negative bacteria
and fungi. Until now, only one molluscan big defensin was identified
from bay scallop Argopecten irradians. The recombinant AiBD could
inhibit the growth of both Gram-positive and Gram-negative
bacteria, and also showed strong fungicidal activity towards yeast
[15]. However, little information is available about the molecular
features and immune response against pathogen infection in the
commercially cultured clam Venerupis philippinarum. The main
objectives of the present study are to: (1) clone the full-length cDNA
of big defensin from V. philippinarum (VpBD); (2) investigate the
expression profile of VpBD post infection of Vibrio pathogen; (3)
elucidate the antibacterial activity of the recombinant VpBD in vitro.
Results
cDNA cloning and sequence analysis of VpBD
A 640 bp fragment representing the complete cDNA of VpBD
was obtained by 59RACE from a cDNA library of V. philippinarum.
The sequence was deposited in GenBank under accession
no. HM562672. The deduced amino acid sequence of VpBD
was shown in Fig. 1. The complete sequence of VpBD cDNA
contained a 59 untranslated region (UTR) of 126 bp, a 39 UTR of
229 bp with a canonical polyA tail, and an open reading frame
(ORF) of 285 bp encoded a polypeptide of 94 amino acids with the
predicted molecular weight of 11.35 kDa and the theoretical
isoelectric point of 9.46. The putative signal peptide was identified
at the N-terminal sequence with the cleavage site at amino acid
position 20. The mature peptide was analyzed using the
antimicrobial peptide predictor program (http://aps.unmc.edu/
AP/prediction/prediction_main.php). The results showed that
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structure formation, a net positive charge (+5) and a high
percentage of hydrophobic residues (36%).
Homology analysis of VpBD
The deduced amino acid sequence of VpBD was aligned with
other known big defensins by CLUSTALW program and low
similarities were found between VpBD and other counterparts
(14% –20%). The consensus pattern C-X6-C-X3-C-X13(14)-C-
X4-C-C in defensin domain was relatively conserved as typically
observed in big defensin from horseshoe crab and bay scallop
(Fig. 2). The disulfide array in VpBD was postulated to be identical
to that of big defensin from horseshoe crab (C1–C5, C2–C4, and
C3–C6).
The expression profile of VpBD after Vibrio challenge
The temporal mRNA expression of VpBD in the haemocytes
post-Vibrio challenge was shown in Fig. 3. During the first 24 hr
after pathogen challenge, the expression level of VpBD mRNA
was obviously up-regulated and reached 7.4-fold compared to that
of control group. After that, the expression level was decreased
gradually from 24 hr to 96 hr, and the lowest expression level was
detected at 96 hr post-bacterial infection, which was 3.9-fold
higher than that of control group. Significant differences of the
expression level of VpBD were observed at 6 hr (P,0.01), 12 hr
(P,0.05), 24 hr (P,0.01), 48 hr (P,0.05), 72 hr (P,0.05) and
96 hr (P,0.05) post the challenge of Vibrio compared to the
control group.
Characterization of recombinant peptide by
electrophoresis
The recombinant plasmid pET-21a-VpBD was transformed
a n de x p r e s s e di nE. coli BL21(DE3)-pLysS. After IPTG
induction for 3 h, the whole cell lysate analyzed by SDS-PAGE
revealed a distinct band with a molecular weight of 9.75 kDa
(Fig. 4 lane B), which was further purified to homogeneity by
HiTrap Chelating Columns (Fig. 4 lane C). Total of 0.9 mg
purified protein was yield from 50 ml bacterial culture in the
end.
MIC assay of the rVpBD
The spectrum of antimicrobial activity of the purified rVpBD
was investigated against several Gram-positive and Gram-negative
bacteria. The rVpBD could inhibit the growth of all tested
microorganisms (Table 1), indicating that rVpBD was a broad-
spectrum antibacterial peptide. The highest activity was found
against Staphyloccocus aureus and Pseudomonas with the MIC of 1.64–
3.28 mM.
Figure 1. The nucleotide sequence (above) and its deduced
amino acid sequence (below) of VpBD. Nucleotides were
numbered from the first base at the 59end. The signal peptide was
underlined. The asterisk indicated the stop codon.
doi:10.1371/journal.pone.0013480.g001
Figure 2. Multiple alignment of VpBD with other known big defensins. Identical amino acids were in white letters with black background,
and gray background indicated high levels of amino acid similarity.
doi:10.1371/journal.pone.0013480.g002
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Living in an aquatic environment rich in microorganisms,
mollusk has developed effective systems to eliminate noxious
microorganisms [16]. However, knowledge advance on the
function, expression and regulation of immune effectors in
mollusk, especially for AMPs, are still deficient compared with
those of insects and vertebrates. In the present study, the cDNA
encoding a potential big defensin was identified from V.
philippinarum (denoted as VpBD). The deduced amino acid of
VpBD shared common features of AMPs, such as a-helical
structure, net positive charge and high hydrophobic residue ratio.
The arrangement of cysteine residues, their neighboring amino
acid residues and the spacing between cysteine residues are
conserved to previously identified homologues [15,17], which
further indicated that VpBD was a new member of the big
defensin family. However, unlike other known big defensin
sequences, no prepropeptide sequence was identified from the
deduced amino acid of VpBD. The hydrophobic region
Figure 3. Time-course expression level of VpBD transcript in haemocytes after Vibrio anguillarum infection measured by quantitative
real-time PCR at 0 hr, 6 hr, 12 hr, 24 hr, 48 hr, 72 hr and 96 hr. Each symbol and vertical bar represented the mean 6 S.D (n=5). Significant
differences between challenged group and control group were indicated by an asterisk (P,0.05) and two asterisks (P,0.01), respectively.
doi:10.1371/journal.pone.0013480.g003
Figure 4. SDS-PAGE analysis of recombinant VpBD. After
electrophoresis, the gel was visualized by Coomassie brilliant blue
R250 staining. Lane M: protein molecular standard; lane A: negative
control for rVpBD (without induction); lane B: induced expression of
rVpBD; lane C: purified rVpBD.
doi:10.1371/journal.pone.0013480.g004
Table 1. Antimicrobial activity of rVpBD against Gram-
positive and Gram-negative bacteria measured by liquid
growth inhibition assay.
Tested microorganisms MIC value
Gram-positive bacteria
Staphyloccocus aureus 1.64–3.28 mM
Micrococcus luteus .26.26 mM
Bacillus sp. 13.13–26.26 mM
Gram-negative bacteria
Vibrio anguillarum 13.13–26.26 mM
Entherobacter cloacae .26.26 mM
Vibrio ichthyoenteri 3.28–6.56 mM
Pseudomonas putida 1.64–3.28 mM
Proteus mirabilis .26.26 mM
Enterobacter sp. 13.13–26.26 mM
doi:10.1371/journal.pone.0013480.t001
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absent from VpBD. The above differences and the lower
homology between VpBD and other big defensins collectively
indicated that VpBD should be a novel big defensin.
Generally, AMPs could be induced by physical stresses and
infectious pathogens. The transcript of big defensin from scallop
was up-regulated after V. anguillarum challenge with a 131.1-fold
increase at 32 h compared to the control group [15]. Similar
expression pattern was also observed in abalone defensin when
received Vibrios infection [18]. In contrast, significant decrease of
AMPs mRNA expression after Vibrio challenge was observed in
crustin, mytilin B and penaeidin, respectively [19,20,21,22,23]. In
the present study, the expression level of VpBD mRNA was
obviously up-regulated post bacterial challenge, and the peak
expression level was detected at 24 hr with a 7.4-fold increase
compared with that of control group. The recruitment of VpBD-
producing haemocytes into circulating system probably contrib-
uted to the drastic increase of VpBD transcript in the early stage of
bacterial challenge. After that, the expression level gradually
down-regulated, and the lowest expression level was detected at
96 hr post-infection, which was still 3.9-fold higher than the
control group. It was postulated that the decreased expression of
VpBD was related to the progressive clearance of the invasive
pathogens. All these results indicated that VpBD was one of the
acute phase proteins involved in the elimination of invasive
pathogens.
It is important to understand the microbicidal activities of
VpBD in vitro. In the present study, the mature peptide of VpBD
was expressed in E. coli BL21(DE3)-pLysS, and the purified
rVpBD exhibited broad-spectrum bactericidal activity towards
various bacteria, which was almost consistent with recombinant
big defensin from scallop [15] and native protein from horseshoe
crab [17]. The same potency and inhibitory effect on growth of
Gram-negative (P. putida) and Gram-positive bacteria (S. aureus)
was also detected for VpBD as big defensin from horseshoe crab
[17]. Compared to other molluscan AMPs, the inhibitory activity
of VpBD was similar or even more efficient. The MIC of mytilin A
towards different bacteria ranged from 0.6 mM to 10 mM
[20,24], while the recombinant defensin from Crassostrea gigas
showed inhibitory activity towards tested microorganism at mM
level [25]. The potent antimicrobial activities of VpBD made it
valuable to control outbreak of pathogenic microorganisms in
clam culture.
Materials and Methods
Clams and bacterial challenge
The clams V. philippinarum (7.5–11 g in weight) were purchased
from a local market and acclimated for a week before
commencement of the experiment. The temperature was held at
20–22uC throughout the whole experiment. The salinity for the
supplied seawater was kept at 30%. For the bacterial challenge
experiment, the clams were randomly divided into six flat-
bottomed rectangular tanks with 50 liter capacity, each containing
50 clams. One tank served as control, while the other five tanks
were immersed with high density of V. anguillarum with a final
concentration of 10
7CFU mL
21. The infected clams were
randomly sampled at 6 hr, 12 hr, 24 hr, 48 hr, 72 hr and 96 hr,
respectively. The clams cultured in the normal seawater were used
as control group. The haemolymphs from the control and the
treated groups were collected using a syringe individually and
centrifuged at 20006g,4 uC for 10 min to harvest the haemocytes.
There were five replicates for each treatment and the control
group.
cDNA library construction and EST analysis
One clam was randomly selected for cDNA library construction at
8h rp o s tV. anguillarum challenge. The cDNA library was constructed
using the ZAP-cDNA synthesis kit and ZAP-cDNA GigapackIII
Gold cloning kit (Stratagene). Random sequencing of the library
using T3 primer yielded 3226 successful sequencing reactions.
BLAST analysis of all the 3226 EST sequences revealed that one
EST of 387 bp was highly similar to the previously identified big
defensins. Therefore, the EST sequence was selected for further
cloning of the full-length cDNA of big defensin from V. philippinarum.
RNA isolation and cDNA synthesis
Total RNA was isolated from the haemocytes of clams using the
TRIzol reagent (Invitrogen). First-strand cDNA synthesis was
performed according to Promega M-MLV RT Usage information
with the RQ1 RNase-Free DNase (Promega)-treated total RNA
(1 mg) as template and oligo (dT) primer. The reactions were
incubated at 42uC for 1 hr, terminated by heating at 95uC for
5 min. For 59 RACE, terminal deoxynucleotidyl transferase
(Takara) was used to add homopolymer dCTP tails to the 3’
end of the purified first-strand cDNA.
Cloning of the full-length cDNA of VpBD by 59RACE
Gene-specific primers, P1 and P2 (Table 2), were designed
based on the EST to clone the full-sequence cDNA of VpBD.
Semi-nested PCR approaches were employed to get the 59end of
VpBD with 1:50 dilution of the first round PCR products as
templates and oligodG as anchored primer. The PCR programs
and PCR product sequencing were performed according to
previously described [26]. The validity of VpBD cDNA was
further verified with primer sets of P3 and P4.
Sequence analysis of VpBD
The VpBD sequence was analyzed using the BLAST algorithm
at NCBI web site (http://www.ncbi.nlm.nih.gov/blast), and the
deduced amino acid sequence was analyzed with the Expert Protein
Analysis System (http://www.expasy.org/). Sequence alignment of
VpBD was performed with the ClustalW Multiple Alignment
program (http://www.ebi.ac.uk/clustalw/) and Multiple Align-
ment show program (http://www.biosoft.net/sms/index.html).
mRNA expression profile of VpBD post V. anguillarum
challenge
The expression of VpBD transcript in haemocytes after Vibrio
challenge was measured by quantitative real time RT-PCR in
Applied Biosystem 7500 fast Real-time PCR System. Gene-specific
primers P5 and P6 (Table 2) were designed to amplify a PCR
product of 101 bp. The product was purified and sequenced to
verify the PCR specificity. Two clam b-actin primers, P7 and P8
(Table 2)wereused to amplify a 121 bpfragment as internal control
to verify the successful reverse transcription and to calibrate the
cDNA template. The reaction component, thermal profile, and the
data analysis were conducted as previously described [26]. All data
were given in terms of relative mRNA expression as means 6 S.E.
The results were subjected to One-way Analysis of Variance
(ANOVA) to determine differences in the mean values among the
treatments. Significance was concluded at P,0.05. Statistical
analysis was performed using SPSS 11.5 for Windows.
Recombinant expression of VpBD and protein
purification
PCR fragment encoding the mature peptide of VpBD was
amplified with gene-specific primers P9 and P10 with Nde I and
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product was cloned into pMD18-T simple vector (Takara),
digested completely by restriction enzymes Nde I and Xho I
(NEB), and then subcloned into the Nde I/Xho I sites of
expression vector pET-21a(+) (Novagen). The recombinant
plasmid (pET-21a-VpBD) was transformed into Escherichia coli
BL21 (DE3)-plysS (Novagen) and subjected to DNA sequencing.
After sequencing to ensure in-frame insertion, positive clones were
incubated in SOB medium (containing 50 mg/L ampicillin) at
37uC with shaking at 220 rpm. When the culture reached OD600
of 0.6, IPTG with final concentration of 1 mmol/L was added to
the culture, and incubated for additional 3 hr under the same
conditions. Cells were harvested by centrifugation at 10,000 g for
2 min, and suspended in 50 mM Tris containing 5 mM EDTA,
50 mM NaCl, and 5% Glycerol (pH 7.9). After being sonicated at
4uC for 60 min, the rVpBD was purified by HisTrap Chelating
Columns (Amersham Biosciences) according to the manufacturer’s
instruction. The purified protein was subjected to 15% SDS-
PAGE according to the method of Laemmli [27]. The
concentration of rVpBD was measured by BCA Protein Assay Kit.
Antimicrobial activity of rVpBD
Antibacterial testing was carried out using three Gram-positive
bacteria (Staphyloccocus aureus, Micrococcus luteus and Bacillus sp) and
six Gram-negative bacteria (Vibrio anguillarum, Entherobacter cloacae,
Pseudomonas putida, Proteus mirabilis, Vibrio ichthyoenteri and Enterobacter
sp.). The MIC was determined according to the method of
Hancock (http://cmdr.ubc.ca/bobh/methods/). The assay was
done with triplicates in three independent experiments. The MIC
value was recorded as the range between the highest concentration
of the protein where bacterial growth was observed and the lowest
concentration that caused 100% inhibition of bacteria growth.
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